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Perceived access and barriers to care
among illicit drug users and hazardous
drinkers: findings from the Seek, Test, Treat,
and Retain data harmonization initiative
(STTR)
Mika Matsuzaki1* , Quan M. Vu2, Marya Gwadz3, Joseph A. C. Delaney1, Irene Kuo4, Maria Esther Perez Trejo1,
William E. Cunningham5, Chinazo O. Cunningham6 and Katerina Christopoulos7

Abstract
Background: Illicit drug use (DU) and hazardous drinking (HD) among marginalized populations may be associated
with greater barriers to care.
Methods: We used baseline data on the participants of the Seek, Test, Treat, and Retain data harmonization initiative.
DU includes use of any illicit drugs within the past 6 months. HD was defined as scores ≥8 for men and ≥ 7 for
women on Alcohol Use Disorders Identification Test within the past 12 months. Social support scores were assigned by
summing scores from individual questions related to social support. Two outcomes for multivariable regression models
and mediation analysis were perceived access to care and perceived barriers to care scores, calculated from summated
points from individual questions within each domain. All models were adjusted for age, gender, race/ethnicity, and
social support and stratified by HIV status.
Results: Among 1403 illicit drug users and 4984 non-drug users, the mean age was 39.6 ± 12.2 years old, 71% were
male, 57% African Americans, and 39% Hispanic/Latinos. Over 25% reported difficulties in covering medical costs and
finding transportation to health care facilities and greater proportions of drug users and hazardous drinkers reported
these issues than non-DU/non-HD. In multivariable models, DU and HD were both independently associated with
having greater barriers to care (β: 0.49 (95% confidence interval: 0.19 to 0.79) p < 0.01; 0.31 (0.18 to 0.45) < 0.01) in
HIV-negative participants. Neither DU nor HD was strongly associated with barriers to care for HIV-positive participants.
Social support was associated with better perceived access to care and fewer barriers to care in the HIV-negative
participants.
Conclusion: The current study found that financial burdens of care, logistical difficulties in accessing care, and low
social support were common challenges among individuals using illicit drugs and/or drinking hazardously. Addressing
structural barriers and strengthening social support may be important strategies to improve health care among
marginalized populations, regardless of HIV status.
Keywords: Barriers to care, HIV/AIDS, Substance use, Race/ethnicity, Social support
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Background
Socioeconomically marginalized populations are known to
receive worse health care than more privileged populations in the United States. In the 2011 National Healthcare
Quality and Disparities Reports, low-income populations
reported worse access to care for 89% of access measures
compared to high-income populations; African Americans
and Hispanics/Latinos also had worse access to care than
Whites for 32% and 63% of access measures, respectively
[1]. Many different types of barriers to health care exist,
including high costs of medical care, the need for insurance coverage, logistical concerns (i.e. travel time, clinic
hours, means of transportation), and linguistic and cultural differences [2–5]. Low trust in health care systems
and professionals is another common barrier to care,
especially among racial/ethnic and sexual minority groups
[6–8]. Specific types of barriers to care may vary within
marginalized populations, for instance, by racial/ethnic
background, HIV status, and substance use patterns.
Substance use is a pressing public health issue in the
U.S. Recent national estimates showed that over 78 million people (29.8%) above age 12 years had used illicit
drugs other than marijuana during their lifetime [9, 10]
and over 15 million adults (6.2%) had alcohol use disorder [11]. The 2013 estimates suggested that those with
lower socioeconomic status experienced greater illicit
drug use; those without high school degrees had the
highest rate (11.8%) of current illicit drug use while it
was lowest among college graduates (6.7%); current illicit
drug use was also higher among unemployed adults
(18.2%) in comparison to full-time employees (9.1%)
[12]. In contrast, the rate of alcohol use was higher
among more highly educated adults; however, binge and
heavy alcohol use was less likely among college graduates than those without college degrees [12]. Abuse of
illicit drugs and alcohol are linked to several health
issues including hepatitis C, HIV/AIDS, and cardiovascular complications [13, 14]. Substance use also contributes to a significant economic cost due to crime, lost
work productivity, and health care needs [15]. Additionally, HIV infection, which disproportionately affects
African Americans and Hispanics/Latinos, may have
mixed effects on barriers to care [16, 17]. HIV infection
may lead to better access to care through broadened eligibility for medical care but also add to existing barriers
to care through disability and financial burden caused by
the disease [2, 18]. The diverse range of problems faced
by marginalized populations suggests a need to carefully
examine how the intersections of substance use and HIV
status are associated with perceived access and barriers
to care. Additionally, previous research has suggested a
positive impact of social support on health outcomes
and behaviors [19]. It is important to assess whether the
presence of social support may affect the association
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between substance use, HIV status, and access and barriers to care in marginalized populations.
The National Institute on Drug Abuse funded “Seek,
Test, Treat, Retain” (STTR) data harmonization initiative
provides a unique opportunity to examine populations who
are typically difficult to reach because of marginalization
due to race/ethnicity, substance use, incarceration history,
and HIV status. The STTR consortium consists of twentythree observational studies and randomized controlled trials that assessed ways to improve HIV testing outreach to
high-risk populations, and for those known to be HIVinfected, ART initiation and retention in long-term care
and treatment [20, 21]. The current analyses included
baseline data from six STTR studies that collected information related to perceived access and barriers to health
care, using standardized questionnaires. Participants were
identified as vulnerable populations living in urban settings, because they either had recent criminal justice involvement or received care at safety-net settings and were
at risk for or already had HIV infection and/or substance
abuse issues.
The current study harmonized data among consortium studies in order to assess various kinds of barriers to care faced by subgroups of a marginalized
population as well as differences in perceived access
and barriers to care by substance use and HIV status
and the role of social support in these associations.
The overall aim was to gain insight into issues related
to access to care that could be useful for planning interventions to improve access to and quality of care
for marginalized populations.

Methods
Study settings

The current analyses used baseline data from six studies
(BCAP/BCU, C4C, FIRST, STAR, BRIGHT2, STTCOIPPrison) in the STTR consortium [21–23]. These six
studies were selected based on availability of data on
measures related to access and barriers to care and drug
and alcohol use. The study participants were all from
urban settings in the United States (New York, San
Francisco, Baltimore, and Chicago). Assessments in
these studies were completed between April 2011 and
November 2015. The summary of the studies included
in the current analyses is shown in Additional file 1:
Table S6.
Measurements
Exposure variables and covariates

All included studies administered structured questionnaires to collect data on self-reported demographic characteristics (age, gender, race/ethnicity, and education),
social support, and substance use patterns. Those who
identified as transgender were not included in the
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analysis as they may face unique challenges but the sample size was too small to conduct meaningful analyses
(n = 17). Education level was categorized into 3 groups
based on the highest degrees obtained: Less than high
school, high school diploma/some college education,
and college degrees and above. The Alcohol Use Disorder Identification Test (AUDIT) was used to identify
hazardous drinking patterns (≥7 for women; ≥8 for men)
over the past 6 months (C4C, STTCOIP-Prison) or the
past year (BCAP/BCU, FIRST, STAR) [24, 25]. Illicit
drug use was defined as recent use of any illicit drugs in
the past 30 days (BCAP/BCU, FIRST, STAR), 90 days
(BRIGHT2), and 6 months (C4C, STTCOIP-Prison).
The definition of illicit drugs does not include marijuana
but both illicit drug users and non-drug users included
some marijuana users. Illicit drug use included all routes
of administration. HIV status was determined by serological testing conducted within each study (BCAP,
BCU, STAR, C4C, BRIGHT2) or medical records (FIRST
and STT-COIP Prison). Social support score was based
on summated points from 5 questions related to social
support developed from previous tools designed to assess social support among HIV-positive individuals
(Additional file 1: Table S7), which asked how often each
of the kinds of support was available to the participants
over the past 4 weeks if they needed it and the answers
ranged from 1 to 5 (“none of the time” to “all of the
time”) [26, 27].
Outcome measures of perceived access and barriers to care

Thirteen questions addressing issues related to access
and barriers to care were constructed for the STTR initiative based on previous studies, as listed in Tables 2
and 3 [2, 3, 28]. There were 6 items in the domain of
perceived access to care and 7 items for barriers to care.
Items related to perceived access to care were asked on
a Likert scale (1–5; strongly agree to strongly disagree)
while barriers to care required binary answers (yes/no).
For perceived access to care, all responses were assigned
values where higher values indicated better conditions to
align the direction of the scales. For example, in the
question “If I need medical care, I can get admitted
without any trouble”, those strongly agreeing to the
statement were given 5 while those strongly disagreeing
with “It is hard for me to get medical care in an emergency” were also given 5. For barriers to care, lower
scores (i.e. having fewer barriers) indicated better conditions. For descriptive comparison, those who had scores
1 or 2 for each question in access to care and 1 for barriers to care were categorized as having difficulties.
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hazardous drinkers/abstainers (HD-), and hazardous
drinkers (HD+). The proportion of participants reporting barriers for each individual item was calculated for
comparison by illicit drug use status, hazardous drinking
patterns, gender, and HIV status. Two-proportions ztests were performed to compare the proportions reporting worse access of care or barriers to care among DU-/
HD- to each of the substance use groups (DU-/HD+,
DU+/HD-, DU+/HD+). For comparison of mean domain
scores among subgroups, a standardized score for each
domain was calculated by summating points from individual items and standardizing them by subtracting the
mean from the summated points and dividing by the
standard deviation [29]. These standardized scores were
plotted in boxplots in four subgroups defined by substance use pattern (illicit drug use or hazardous drinking) and HIV status. Jitter plots were overlaid to show
the density and distribution of the score for each subgroup. Mean standardized scores were also shown on
the graph. The Welch two-sample t-test was used to
compare mean values among subgroups.
For multivariable linear regression analyses, the raw
score for each domain (i.e. summated points from individual questions within each domain) was used for outcomes.
The associations of these scores with drug use and hazardous drinking were examined in multivariable regression
models adjusting for age, gender, race/ethnicity, and social
support. All models were stratified by HIV status. Multilevel regression models were also fit to test study-level differences but the intraclass correlations for the study level
were small (0.01 to 0.15), and therefore simple regression
models were chosen. Mediation analyses were also performed to see how much of the association between substance use and access and barriers to care could be
explained by social support, if social support were a mediator between substance use and perceived access and barriers to care. Separate analyses were performed for both
types of substance use (drug use and hazardous drinking),
using the following models: 1) mediator conditioned on exposure (social support on substance use, adjusting for age,
gender, race/ethnicity, the other type of substance use) and
2) outcome conditioned on exposure and mediator (score
from each domain on drug use, hazardous drinking, and
social support, adjusting for age, gender, and race/ethnicity). The mediation analysis was only retained in HIVnegative participants as the association between the mediator and exposure was not observed in HIV-positive participants. All analyses were performed in R (Version 3.0.2).

Results

Statistical analysis

Descriptive statistics
Characteristics of the participants

Descriptive statistics were calculated for the total population, non-drug users (DU-), drug users (DU+), non-

A total of 6387 participants were included in this study,
among whom 71% were male and most were from
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minority populations (57% Blacks/African Americans
and 39% Hispanics/Latinos) (Table 1). The median age
was 42 years old (range 18–75). Educational attainment
was low; 35% had less than high school degree in comparison to 11.6% in the general population in the U.S.
in 2015 [30]. Among HIV-positive participants, 56% reported having recently used illicit drugs, considerably
higher than the HIV-negative participants (17%).
Higher proportions of Hispanic/Latino participants reported having used illicit drugs recently (30%) and
drunk hazardously (38%) than African American participants (15% and 26% respectively). Thirty-five to 48 %
of the population reported not having someone to help
buy medicines, help with transportation, or provide financial assistance when needed (Additional file 1:
Table S7). Greater proportions of HIV-positive participants and men reported having less support on all
items related to social support than HIV-negative

participants and women respectively (Additional file 1:
Table S7).
Access to care

Nearly one-third (29%) of the study population reported
that they sometimes go without the medical care they
need because it is too expensive, which is similar to the
general population (27%) (Table 2) [31]. More than one
quarter of the study population reported not having easy
access to medical specialists. Men perceived having
worse access to care than women (Additional file 1:
Table S8). Difficulties with medical expense and access
to specialists were more commonly reported among the
HIV-negative participants than HIV-positive participants
(Additional file 1: Table S8). As shown in Fig. 1, HIVpositive illicit drug users (DU+) participants had overall
better perceived access to care than HIV-negative DU+
participants (mean ± standard deviation (sd): 0.23 ± 0.99

Table 1 Characteristics of the study participants
Age (years) mean (sd)

All

DU-a

DU+a

HD-

HD+

n = 6387

4984

1403

4261

1889

39.6(12.2)

38.3(12.4)

43.8(10.5)

38.8(12.6)

41.2 (11.3)

Gender n (%)
Men

4557 (71.3)

3316 (66.5)

1241 (88.5)

2824 (66.3)

1567 (83.0)

Women

1830 (28.7)

1668 (33.5)

162 (11.5)

1437 (33.7)

322 (17.0)

2475 (38.8)

1736 (34.8)

739 (52.7)

1514 (35.5)

931 (49.3)

Race n (%)
Hispanic/Latino
Black/African American

3651 (57.2)

3118 (62.6)

533 (38)

2556 (60)

898 (47.5)

White/Asian

107 (1.7)

24 (0.5)

83 (5.9)

83 (1.9)

21 (1.1)

Other

154 (2.4)

106 (2.1)

48 (3.4)

108 (2.5)

39 (2.1)

HIV status n (%)
Negative

5509 (86.3)

4594 (92.2)

915 (65.2)

3721 (87.3)

1663 (88.0)

Positive

878 (13.7)

390 (7.8)

488 (34.8)

540 (12.7)

226 (12.0)

No

4261 (69.3)

3531 (73.7)

730 (53.7)

Yes

1889 (30.7)

1259 (26.3)

630 (46.3)

Hazardous drinkingb n (%)

Education n (%)
Less than high school

2217 (34.8)

1755 (35.3)

462 (33)

1439 (33.8)

691 (36.6)

High school/some college

3901 (61.2)

3034 (61)

867 (61.8)

2637 (62)

1129 (59.9)

College degree or higher

256 (4)

183 (3.7)

73 (5.2)

178 (4.2)

66 (3.5)

No

1763 (35.3)

1317 (33)

446 (44.6)

1107 (32.6)

612 (41.5)

Yes

3232 (64.7)

2679 (67)

553 (55.4)

2290 (67.4)

864 (58.5)

Social supportc n (%)

All participants have data on gender (men/women), race (black/African American, Hispanic/Latino, White/Asian, Other), and HIV status (positive/negative) and
answered all questions within either or both domains of barriers to care (perceived access to care; barriers to care). Those who refused to answer race/ethnicity
questions were categorized under “Other” (n = 22). Those who identified as transgender were not included in the analyses
Percentages are calculated for each characteristic (i.e. Race) within each substance use group
DU illicit drug users, HD hazardous drinkers
a
Some of the DU- and DU+ may concurrently use alcohol and marijuana
b
Hazardous drinking is defined by AUDIT score ≥ 8 (male) and 7 (female)
c
Social support (yes) is assigned to participants who reported having support in the majority of the items on the social support questionnaire (≥3 items)
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Table 2 Proportions reporting difficulties in access to care by substance use patterns
All

Substance use patterns
no DU and DU only
no HDa

HD only

DU and
HD

n

n

n

Perceived Access to Care

n

If I need medical care, I can get admitted without any trouble (% disagree)

3548 11.4 2325 11.6 319 11

620 11

It is hard for me to get medical care in an emergency (% agree)

3554 19.8 2329 18.8 319 19.4

620 22.7* 152 21.1

I have easy access to the medical specialists that I need. (% disagree)

3546 26.9 2326 26.4 319 16.3** 619 30.4

152 18.4*

I am able to get medical care whenever I need it (% disagree)

3557 12.7 2332 11.1 319 12.5

622 14

152 14.5

319 17.2

621 14.7

152 19.1*

Sometimes I go without the medical care I need because it is too expensive (% agree) 3551 28.6 2326 27.7 319 25.7

622 31.7

152 23

Places where I can get medical care are very conveniently located (% disagree)

%

%

3552 13.7 2328 12

n

%

**

%

%

152 7.2

Two-proportions z-test was performed between no DU or HD group and each of the substance use groups (DU only, HD only, DU and HD). * indicates p < 0.05
and ** indicates p < 0.01
DU illicit drug users, HD hazardous drinkers
a
This group includes participants who consume alcohol but do not drink hazardously

and − 0.43 ± 1.01 respectively; p for the difference <
0.001). The difference in overall perceived access to care
between HIV-negative and HIV-positive participants was
much larger among DU+ than non-drug users (DU-)
(Fig. 1). HIV-positive participants had higher mean
scores than HIV-negative participants in both HD- and
HD+ groups.
Barriers to care

Seventeen percent of the study participants were uninsured. DU+ and HD+ generally reported more barriers
to care than DU-/HD- (Table 3). More than 18% of substance users reported having been treated poorly at a
clinic in the past in comparison to 14% for DU-/HD-.
Inability to pay for medical care and lack of a means of
transportation were common barriers reported in the
study population. Higher proportion of the DU+/HD+
participants (21%) reported mistrust in doctors than
DU-/HD-, DU+/HD-, and DU-/HD+ (11%, 17%, and
15% respectively). Men reported more barriers to care

than women on all items, including the lack of insurance
(19.2% in men and 9.7% in women) (Additional file 1:
Table S8). There were similar trends for overall barriers
to care in DU and HD (Fig. 2): HIV-negative DU+ and
HD+ groups had higher mean standardized scores for
barriers to care than the other subgroups. The differences in mean standardized scores by HIV status were
small among non-substance users. HIV-positive HD+
and DU+ groups had similar mean standardized scores
as HD- and DU-.
Multivariable regression models

Illicit drug use was associated with worse perceived access to care in HIV-negative participants (β: − 1.42 (95%
confidence interval (CI): − 2.38 to − 0.45)), adjusting for
age, gender, race/ethnicity, and social support (Table 4).
In HIV-negative participants, both illicit drug use and
hazardous drinking were strongly associated with greater
barriers to care (β: 0.49 (95% CI: 0.19 to 0.79) and 0.31
(0.18 to 0.45) respectively). However, there was no

Fig. 1 Distribution of perceived access to care scores by HIV status and substance use patterns. Each box represents the 1st to 3rd quartiles with
the median line. The jitter plots show the standardized score distributions. The mean values are marked as red dots and the values are noted
under each boxplot. The whiskers indicated the lowest and highest values within 1.5 times 1st and 3rd quartile values. For this domain, higher
standardized scores indicate better conditions
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Table 3 Proportions reporting barriers to care by substance use patterns
All

Substance use patterns
no DU and no HDa

DU only

HD only

DU and HD

Barriers to care: “Think of the last time you did not get the medical
treatment recommended for you”

n

%

n

%

n

%

n

%

n

%

I was unable to pay for medical care (% agree)

3448

27.9

2388

25.7

263

27**

632

34.8**

126

32.5**

**

**

I did not have transportation to medical care (% agree)

3476

26.4

2386

23

287

34.5

632

32.1

134

42.5**

The clinic’s hours of operation were inconvenient for me (% agree)

3474

18.2

2386

16

287

22.3**

631

21.6**

134

27.6**

I did not have child care (% agree)

3444

10.2

2361

9.8

287

8.7

627

11.3

I was treated poorly at a clinic in the past (% agree)

3481

16

2390

13.7

287

**

17.8

**

632

131

10.7

**

134

24.6**

*

21.4

I do not trust doctors (% agree)

3468

12.9

2383

11.3

286

17.1

628

14.6

134

20.9**

Uninsured (%)

6342

16.5

3512

15.9

720

12.9

1254

17.1

622

20.4**

Two-proportions z-test was performed between no DU or HD group and each of the substance use groups (DU only, HD only, DU and HD). * indicates p < 0.05
and ** indicates p < 0.01
DU illicit drug use, HD hazardous drinking
a
This group includes participants who consume alcohol but do not drink hazardously

evidence for association between substance use and barriers to care in HIV-positive participants. There were no
interactions between social support and DU or HD in
these models. Social support was positively associated
with perceived access to care and inversely with barriers
to care in HIV-negative participants.
Mediation analysis

We also explored a possibility of mediation by social
support in the association between substance use and
perceived access and barriers to care. In HIV-positive
participants, there was no strong evidence for the association between social support and DU/HD, and therefore
mediation analysis was not undertaken (Additional file 1:
Table S9). In HIV-negative participants, there was evidence of mediation by social support between hazardous
drinking and both perceived access to care (ACME: −
0.24 (− 0.35 to − 0.15) p < 0.01; proportion mediated 0.42
(0.2 to 1.61 p = 0.01) and barriers to care (ACME: 0.06

(0.04 to 0.09) p < 0.01; proportion mediated 0.16 (0.09 to
0.29) p < 0.01) (Table 5); however, the mediation effect
was not apparent in the association between drug use
and measures of perceived access and barriers to care.

Discussion
The current study found that recent illicit drug use and
hazardous drinking as well as low social support were
associated with greater barriers to care in the HIVnegative participants. Among HIV-positive participants,
this association was less prominent. Financial burden of
care, logistical difficulties in accessing care, and lack of
social support were commonly reported in this marginalized population.
Comparison with previous studies

Previous research has shown that the intersection of
substance use and HIV can present significant challenges
for both the patients and health care systems [32]. Illicit

Fig. 2 Distribution of perceived barriers to care scores by HIV status and substance use patterns. Each box represents the 1st to 3rd quartiles with
the median line. The jitter plots show the standardized score distributions. The mean values are marked as red dots and the values are noted
under each boxplot. The whiskers indicated the lowest and highest values within 1.5 times 1st and 3rd quartile values. For this domain, lower
standardized scores indicate better conditions
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Table 4 Multivariable regression models assessing association of drug use and hazardous drinking with perceived access to care
and barriers to care, stratified by HIV status
Perceived access to carea
Better condition

Barriers to carea

Higher score
β (95%CI)

Lower score
p

β (95%CI)

n = 2895

HIV-negative

s

n = 2832

Illicit drug use (yes)

−1.42 (−2.38 to −0.45)

< 0.01

0.49 (0.19 to 0.79)

< 0.01

Hazardous drinking (yes)

−0.34 (−0.78 to 0.11)

0.14

0.31 (0.18 to 0.45)

< 0.01

Social support

0.18 (0.15 to 0.22)

< 0.01

− 0.05 (− 0.06 to − 0.04)

< 0.01

n = 263

HIV-positive

n = 253

Illicit drug use (yes)

1.89 (0.56 to 3.22)

0.01

− 0.01 (− 0.39 to 0.38)

0.97

Hazardous drinking (yes)

0.18 (− 0.96 to 1.32)

0.75

−0.03 (− 0.43 to 0.37)

0.86

0.18 (0.09 to 0.28)

< 0.01

−0.02 (− 0.05 to 0.01)

0.15

a

Social support

All models were adjusted for age, gender, and race/ethnicity
a
Scores were based on summation of points from individual questions within each domain (perceived access to care: 6 questions; barriers to care: 7; social
support: 5). The domain score ranges were: perceived access to care 5–30 points; barriers to care 0–7 points; social support 5–25 points

drug users may be less motivated to use routine health
care to avoid inquiry and monitoring of their drug use
while at the same time, they may be more likely to
present for emergency room visits and hospital care
[33]. The underlying mechanisms for low usage of routine care among illicit drug users include comorbid psychiatric conditions such as depression and bipolar
disorder as well as mistrust in health care professionals
and systems [32, 34, 35]. Alcohol abuse is also associated
with a number of psychiatric comorbidities, which may
contribute to worse access and greater barriers to care
[36]. Illicit drug users are also more likely to have alcohol disorder [37]. We observed this association in the
current study, where the prevalence of hazardous drinking was much higher among illicit drug users than nondrug users (46% vs 26%). It is important to understand
how each condition, as well as combinations of these

conditions, is associated with barriers to care. In our
study, the participants who were both using illicit drugs
and drinking hazardously reported having more logistical issues, less trust in health care, and less social support than those who only used illicit drugs or drank
hazardously, although we did not observe interaction effects between illicit drug use and hazardous drinking in
our multivariable models.
In our study population, HIV infection was common
among illicit drug users. In the United States, the HIV
epidemic disproportionately affects impoverished individuals in urban settings and minority populations [16,
17, 38]. Even though HIV infection greatly increases the
need for receiving continuous care, engagement in and
adherence to HIV care remains a major public health
challenge; in 2014, only 58% of HIV-positive people
achieved viral suppression [39]. Studies have reported

Table 5 Mediation effects by social support in the association of drug use and hazardous drinking with perceived barriers to care
and barriers to care in HIV-negative participants
Better condition

Perceived access to care

Barriers to care

Higher score

Lower score

Illicit drug use
ACME

−0.17 (− 0.35 to 0)

0.06

0.05 (− 0.01 to 0.1)

0.07

ADE

− 1.42 (− 2.33 to − 0.37)

< 0.01

0.49 (0.13 to 0.86)

0.02

Total effects

− 1.59 (− 2.58 to − 0.53)

< 0.01

0.54 (0.18 to 0.92)

0.01

Proportion mediated

0.11 (0 to 0.32)

0.07

0.09 (− 0.02 to 0.3)

0.08

ACME

−0.24 (− 0.35 to − 0.15)

< 0.01

0.06 (0.04 to 0.09)

< 0.01

ADE

−0.34 (− 0.78 to 0.11)

0.18

0.31 (0.17 to 0.45)

< 0.01

Total effects

−0.58 (− 1.03 to − 0.13)

0.01

0.38 (0.23 to 0.51)

< 0.01

Proportion mediated

0.42 (0.2 to 1.61)

0.01

0.16 (0.09 to 0.29)

< 0.01

Hazardous drinking

All models were adjusted for age, gender, race/ethnicity
ACME Average Causal Mediation Effects, ADE Average direct effect
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poor adherence to HIV care among drug users [40–42].
The mechanisms underlying the association between
HIV infection and health care are complex; on the one
hand, HIV-infected individuals may experience other comorbidities as well as greater stigma and financial difficulties, which may prevent them from attending clinics
even if they are available. However, they also have
greater needs for regular treatment, which may motivate
them to seek routine care, and there is also a strong
public infrastructure to support the care of HIV-infected
individuals in the U.S [43]. In our study, we saw that HIVpositive participants had, on average, a better aggregate
score of perceived access to care, suggesting that some factors associated with being infected with HIV (i.e. strong
public clinic infrastructure, personal health needs, programs to link HIV-infected individuals to care, and AIDS
drug assistance programs) may potentially counteract adverse conditions associated with HIV infection. In addition
to having more comprehensive and resourced care, HIV
providers may be less stigmatizing and discriminatory towards people who use drugs than providers who care for
HIV-negative patients, since HIV providers often encounter substance use in their patients. This may partially explain better perceived access to care we saw among HIVpositive substance users, who may receive additional referrals from their providers for substance use treatment.
We also found that social support among HIV-positive
participants was lower than HIV-negative participants.
Social support is thought to alter biological processes
and affect health outcomes through its influence on behavioral and psychological processes [44]. Social support
may influence HIV disease progression physiologically
and psychologically by affecting immune systems as well
as providing functional support to facilitate better adherence to treatment [5, 44–50]. Additionally, HIV infection
may make patients withdraw from social networks,
resulting in a negative feedback loop between social support and the disease status [51, 52]. Likewise, substance
users may also experience this kind of isolation. In our
study, we examined social support as a confounder and
also explored the possibility of its role as a mediator in
the association between substance use and access to
care. In the multivariable models, substance use was
only associated with social support among HIV-negative
participants. This may be because the level of social support is already so low among HIV-positive participants
that drug use and hazardous drinking may not add discernable effects. It is also important to note that there
are other types of social support that may contribute to
better access to care among HIV-positive participants beyond what the current study measured, which focused on
support by families and friends. Future studies are needed
to better understand the associations between different
types of social support and HIV care continuum.
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The study population consisted largely of marginalized
racial/ethnic minority groups (i.e. African Americans or
Hispanic/Latinos living in areas with a high prevalence
of HIV infection, illicit drugs, and criminal history). Research has demonstrated that minority groups receive
lower-quality care and have lower trust in health care
systems than Whites [3, 4]. While socioeconomic factors
like poverty, insurance coverage, and education partially
explain the association between access to care and race/
ethnicity, there may also be an independent effect of
race/ethnicity on access to care [53]. There may also be
variability in types of barriers to care among minority
groups. For instance, a qualitative study found that Hispanics/Latinos may have more linguistic barriers while
African Americans may have lower trust in health care
professionals [54]. In our study, Hispanics/Latinos generally reported greater barriers to care and lower social
support than Blacks/African Americans. However, the
racial/ethnic differences we saw in our study were generally not strong, which is likely due to the fact that we
are comparing two minority groups rather than against a
sizable privileged group.
We also saw that men in our study population perceived having worse access to care than women. In this
study population, the proportion of uninsured men was
greater (19%) than the general population (13%) as well
[55]. Previous research that used the same instrument
for perceived access to care have shown variable results
for gender differences in perceived access to care [56,
57]. One possible explanation for this variability is that
gender differences in perceived access to care may vary
between subpopulations. There is a need to further assess which specific context may contribute to gender differences in perceived access to care in marginalized
populations and how that is associated with health care
utilization.
Public health implications

Given these findings in the current study, we may need
to consider building additional infrastructure to improve
access to care for marginalized populations who are at
risk but not infected with HIV as care for these individuals are not well designed to meet their needs that often
are similar to those for HIV-positive individuals. In the
mediation analysis, there was some evidence that a large
proportion of the association between hazardous drinking and perceived access and barriers to care may be
mediated through social support in HIV-negative individuals. This analysis cannot confirm whether social support is acting as a confounder or a mediator but they do
suggest a need for future studies to elucidate the role of
social support among substance users. If social support
is indeed a mediator of this association, our finding has
an important policy implication, since increasing social
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support could potentially contribute to reduction of barriers to care in marginalized populations. Several studies
have examined effectiveness of social support interventions
and found that types of social support needed may be
highly context-dependent [58]. To add to this complexity,
specific types of barriers to care as well as subgroups of
marginalized populations who experience most difficulties
in access to care may change over time with political climate and cultural shift. There is a need to monitor such
changes and build dynamic infrastructure that can cope
with variable difficulties faced by marginalized populations.
Limitations

The study used cross-sectional data and therefore, we cannot infer causality from our findings. Substance use and
barriers to care may mutually affect each other. The relationships could well be bidirectional; for example, substance use may lead to experiencing greater barriers to
care through loss of motivation and productivity, financial
burden, and social isolation; likewise, experiencing these
difficulties may lead people to initiate or increase substance use, especially for difficult conditions like chronic
pain. If the mechanisms underlying the associations we
saw between substance use and barriers to care are bidirectional, they can mutually result in worse health outcomes, where the problems are self-reinforcing. To break
these issues apart would require careful longitudinal studies. Substance use was based on self-report data and may
be affected by cognitive bias. Our sample size for HIVpositive participants was smaller than the HIV-negative
participants, which makes it difficult to make conclusive
remarks about the lack of association between substance
use and barriers to care in HIV-positive participants. HIVnegative participants came from two studies in New York
and future studies from other cities are necessary to assess
generalizability of our findings. Furthermore, future studies in rural settings are needed to understand any differences in needs among urban and rural residents.
We also did not have information on how these reported barriers may be associated with health care
utilization or health outcomes, both of which are important elements to consider. Not all types of potential
barriers - for instance, linguistic and cultural barriers to
care [4] or food insecurity [59] - could be examined due
to insufficient data availability. The data were taken from
study populations in various locations although all of
these studies were conducted in major urban areas in
the United States and aimed to recruit marginalized
populations, providing some consistency in participant
characteristics.

Conclusions
Drug abuse and hazardous drinking present challenges
to health care access in marginalized populations. The
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participants in this study experienced high degrees of
barriers to care, especially in terms of financial burden,
logistic difficulties in accessing care, and lack of social
support. Our findings suggest the needs to strengthen
infrastructural and social support for marginalized populations regardless of HIV status.
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